Literature DB >> 22862822

The interaction of amylin with other hormones in the control of eating.

T A Lutz1.   

Abstract

Twenty years of research established amylin as an important control of energy homeostasis. Amylin controls nutrient and energy fluxes by reducing energy intake, by modulating nutrient utilization via an inhibition of postprandial glucagon secretion and by increasing energy disposal via a prevention of compensatory decreases of energy expenditure in weight reduced individuals. Like many other gastrointestinal hormones, amylin is secreted in response to meals and it reduces eating by promoting meal-ending satiation. Not surprisingly, amylin interacts with many of these hormones to control eating. These interactions seem to occur at different levels because amylin seems to mediate the eating inhibitory effect of some of these gastrointestinal hormones, and the combination of some of these hormones seems to lead to a stronger reduction in eating than single hormones alone. Amylin's effect on eating is thought to be mediated by a stimulation of specific amylin receptors in the area postrema. Secondary brain sites that were defined to mediate amylin action - and hence potential additional sites of interaction with other hormones - include the nucleus of the solitary tract, the lateral parabrachial nucleus, the lateral hypothalamic area and other hypothalamic nuclei. The focus of this review is to summarize the current knowledge of amylin interactions in the control of eating. In most cases, these interactions have only been studied at a descriptive rather than a mechanistic level and despite the clear knowledge on primary sites of amylin action, the interaction sites between amylin and other hormones are often unknown.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862822     DOI: 10.1111/j.1463-1326.2012.01670.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  20 in total

1.  Amyloidogenicity and cytotoxicity of des-Lys-1 human amylin provides insight into amylin self-assembly and highlights the difficulties of defining amyloidogenicity.

Authors:  Kyung-Hoon Lee; Alexander Zhyvoloup; Daniel Raleigh
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

Review 2.  The endocrinology of food intake.

Authors:  Denovan P Begg; Stephen C Woods
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

3.  Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake.

Authors:  Elizabeth G Mietlicki-Baase; Diana R Olivos; Brianne A Jeffrey; Matthew R Hayes
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

Review 4.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

Review 5.  The physiology underlying Roux-en-Y gastric bypass: a status report.

Authors:  Thomas A Lutz; Marco Bueter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

Review 6.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

Review 7.  Toward a Wiring Diagram Understanding of Appetite Control.

Authors:  Mark L Andermann; Bradford B Lowell
Journal:  Neuron       Date:  2017-08-16       Impact factor: 17.173

Review 8.  GLP-1 and Amylin in the Treatment of Obesity.

Authors:  T Jorsal; J Rungby; F K Knop; T Vilsbøll
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

Review 9.  Amylin activates distributed CNS nuclei to control energy balance.

Authors:  Elizabeth G Mietlicki-Baase; Matthew R Hayes
Journal:  Physiol Behav       Date:  2014-01-28

10.  Amylin modulates the mesolimbic dopamine system to control energy balance.

Authors:  Elizabeth G Mietlicki-Baase; David J Reiner; Jackson J Cone; Diana R Olivos; Lauren E McGrath; Derek J Zimmer; Mitchell F Roitman; Matthew R Hayes
Journal:  Neuropsychopharmacology       Date:  2014-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.